Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), V. Miskiv (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine). New possibilities for modifying the course of chronic obstructive pulmonary disease: the effect of tiotropium bromide on certain pathogenetic links of neocollagenogenesis of the bronchial tree. 866

Member's Comments

No comment yet.

Related content which might interest you: Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 Non-invasive sanitation of a bronchial tree with different phenotypes of chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 Is there any point in treatment of patients with chronic obstructive pulmonary diseases with salmeterol and ipratropium bromide, alone and in combination? Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002 Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease> Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Bronchodilatory effects of formoterol in patients with chronic obstructive pulmonary disease (COPD) are not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 514s Year: 2001 The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Efficacy of tiotropium bromide in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Source: Eur Respir J 2015; 46: 8-10 Year: 2015 Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes Source: Eur Respir J 2003; 21: 30S-35S Year: 2003 Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Source: Eur Respir J 2003; 21: 68-73 Year: 2003 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 Lymphangiogenesis in chronic obstructive pulmonary disease (COPD): New insights in airways remodeling Source: Annual Congress 2010 - Airways and lung mechanics in subjects of all ages Year: 2010 The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002